| Outcome Measures: |
Primary: treatment satisfaction (DTSQs and DTSQc), over whole study duration, 24 weeks per patient | Secondary: diabetes-related quality of life (ADDQoL), over whole study duration, 24 weeks per patient|general health-related quality of life (EQ-5D), over whole study duration, 24 weeks per patient|Body weight, over whole study duration, 24 weeks per patient|metabolic control (HbA1c, fasting morning blood glucose), over whole study duration, 24 weeks per patient|Insulin dose, over whole study duration, 24 weeks per patient|concomitant diabetes therapy (OADs), over whole study duration, 24 weeks per patient|Hypoglycemia, over whole study duration, 24 weeks per patient|Adverse drug reactions, ADR, over whole study duration, 24 weeks per patient|Serious adverse drug reactions, SADR, over whole study duration, 24 weeks per patient|Pregnancy, over whole study duration, 24 weeks per patient
|
